FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32963811000001109: Selexipag 200microgram tablets 140 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100473101000001113 Selexipag 200microgram tablets 140 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100473201000001118 Selexipag 200microgram tablets 140 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selexipag 200microgram tablets 140 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Has VMP Selexipag 200microgram tablets true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 140 tablet Is a True Selexipag 200microgram tablets 140 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start